
CXL for ultra-thin corneas: the sub400 protocol webinar
“CXL for ultra-thin corneas: the sub400 protocol” shows a revolutionary new protocol to treat ultra-thin keratoconic corneas down to 215 µm thickness.

“CXL for ultra-thin corneas: the sub400 protocol” shows a revolutionary new protocol to treat ultra-thin keratoconic corneas down to 215 µm thickness.

Recognizing the most influential people around the globe in ophthalmology, The Ophthalmologist, an internationally recognized magazine, named Prof. Farhad Hafezi MD, PhD, FARVO of the ELZA Institute, Dietikon, Zurich, Switzerland for the fourth consecutive time to its biennial Power List, listing those 100 people who are the most influential in ophthalmology.

Many women with endometriosis receive “selective tissue estrogenic activity regulator” (STEAR) therapy, but this treatment can cause previously stable keratoconus to start progressing – rapidly

ELZA’s Medical Director, Prof. Farhad Hafezi was an invited international guest speaker at the recent 13th Congrès D’Ophthalmologique Practique (AOPA) at the Hotel Sheraton Alger in Algiers. The congress covered all of ophthalmology, but had a large cornea and refractive sessions, where Prof. Hafezi gave presentations on ELZA’s current research work. His podium presentations reviewed ELZA’s research into refractive surgery, corneal cross-linking and PACK-CXL for the treatment of corneal infection. He also celebrated his birthday while attending the congress!

One of most amazing talks was that of Dr. Anat Galor, who presented the topic “Microbiome and Dry Eye”.

This month, Brazil’s top Ophthalmology magazine, Oftalmologica Em Foco, features ELZA’s Prof. Hafezi and Dr. Torres-Netto exploring the story of how CXL at the slit lamp is becoming a reality.

Dion Paridaens speaks about Complications of Orbital Decompression and Their Prevention in Val d’Isere

Brazil’s top Ophthalmology magazine, Oftalmologica Em Foco, features ELZA’s Prof. Hafezi and Dr. Torres-Netto exploring the story of how CXL at the slit lamp is becoming a reality.

Sub400” is a new CXL protocol developted at here at ELZA, that has been successfully used to cross-link KC corneas as thin as 220 µm – without “hacks.

Important innovation in measuring success after cross-linking for keratoconus. Prof. Farhad Hafezi from the ELZA Institute in Switzerland shows the new biomechanics CorVis display.
Stay informed & get the newsletter
You have successfully joined our subscriber list.
Newsletter abonnieren & informiert bleiben
Sie haben sich erfolgreich in unsere Abonnentenliste eingetragen.
Bitte bestätigen Sie Ihr Abonnement, indem Sie auf den Link in der E-Mail klicken, die wir Ihnen gerade geschickt haben.